- Home
- HALO vs NTSK Comparison
HALO vs NTSK Comparison
Compare HALO & NTSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- NTSK
- Stock Information
- Founded
- HALO 1998
- NTSK 2012
- Country
- HALO United States
- NTSK United States
- Employees
- HALO N/A
- NTSK N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- NTSK Computer Software: Prepackaged Software
- Sector
- HALO Health Care
- NTSK Technology
- Exchange
- HALO Nasdaq
- NTSK Nasdaq
- Market Cap
- HALO 9.0B
- NTSK 9.3B
- IPO Year
- HALO N/A
- NTSK 2025
- Fundamental
- Price
- HALO $65.56
- NTSK $22.04
- Analyst Decision
- HALO Buy
- NTSK
- Analyst Count
- HALO 10
- NTSK 0
- Target Price
- HALO $73.40
- NTSK N/A
- AVG Volume (30 Days)
- HALO 2.2M
- NTSK 6.6M
- Earning Date
- HALO 10-30-2025
- NTSK 01-01-0001
- Dividend Yield
- HALO N/A
- NTSK N/A
- EPS Growth
- HALO 68.93
- NTSK N/A
- EPS
- HALO 4.37
- NTSK N/A
- Revenue
- HALO $1,178,672,000.00
- NTSK $615,512,000.00
- Revenue This Year
- HALO $32.57
- NTSK N/A
- Revenue Next Year
- HALO $23.25
- NTSK N/A
- P/E Ratio
- HALO $15.12
- NTSK N/A
- Revenue Growth
- HALO 34.97
- NTSK 32.29
- 52 Week Low
- HALO $42.01
- NTSK $21.02
- 52 Week High
- HALO $79.50
- NTSK $27.99
- Technical
- Relative Strength Index (RSI)
- HALO 31.20
- NTSK N/A
- Support Level
- HALO $73.06
- NTSK N/A
- Resistance Level
- HALO $76.30
- NTSK N/A
- Average True Range (ATR)
- HALO 2.33
- NTSK 0.00
- MACD
- HALO -1.57
- NTSK 0.00
- Stochastic Oscillator
- HALO 3.81
- NTSK 0.00
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.